Cargando…
Effect of PCSK9 Inhibition on the Plasma Proteome: A SPIRE SubStudy
Autores principales: | Kraaijenhof, Jordan M., Opstal, Tjerk S.J., Cornel, Jan H., Gill, Dipender, Hovingh, G. Kees, Catapano, Alberico L., Koenig, Wolfgang, Ridker, Paul M, Stroes, Erik S.G., Nurmohamed, Nick S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364960/ https://www.ncbi.nlm.nih.gov/pubmed/37317854 http://dx.doi.org/10.1161/ATVBAHA.123.319272 |
Ejemplares similares
-
The iterative lipid impact on inflammation in atherosclerosis
por: Kraaijenhof, Jordan M., et al.
Publicado: (2021) -
Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction
por: Nurmohamed, Nick S, et al.
Publicado: (2023) -
Genetically Predicted Neutrophil-to-Lymphocyte Ratio and Coronary Artery Disease: Evidence From Mendelian Randomization
por: Cupido, Arjen J., et al.
Publicado: (2022) -
Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration
por: Ference, Brian A, et al.
Publicado: (2018) -
Different inflammatory pathways underlying cardiovascular risk in secondary prevention( )
por: Nurmohamed, Nick S, et al.
Publicado: (2022)